Drugs / Norethindrone-Ethinyl Estradiol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02245438 | May → Jun 2002 | — | Boehringer Ingelheim | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Norethindrone-Ethinyl Estradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02245438 ↗ |
| Known as | NET/EE | “Norethindrone-Ethinyl Estradiol (NET/EE) 1 mg/ 0.035 mg administered as a single dose” NCT02245438 ↗ |